Navigation Links
Avista Capital Partners Enhances Energy Practice With Appointment of Gerhard Kurz
Date:2/27/2008

ta team at Seabulk, I look forward to partnering with them again. Over the last 40 years, I have built strong relationships within the energy service and marine transportation industries and anticipate leveraging these associations, as well as my own operating experience, in helping Avista make strategic investments in well-positioned businesses in this sector."

Avista has significant experience in the energy sector and has consistently demonstrated its ability to execute transactions quickly and professionally. The firm closed its inaugural $2.0 billion private equity fund in June 2007 and has made investments in 19 portfolio companies broadly diversified in the energy, healthcare and media industries.

Avista's current portfolio of energy companies includes: Geokinetics, a provider of seismic acquisition and data processing services to the international oil and gas industry; Frontier Drilling, which owns and operates deepwater offshore drilling rigs and floating production vessels; Blake Offshore, which owns and operates a fleet of six offshore drilling and production units servicing the Gulf of Mexico oil and gas industry; and Celtique Energie, Laramie Energy, Manti Exploration, and Peregrine Oil and Gas, which are focused on exploration and production of oil and natural gas. In addition, while at DLJ Merchant Banking Partners, the Avista team was significantly involved in many energy investments, including American Ref-Fuel, Basic Energy Services, Caledonia Oil and Gas, Laramie Energy, Medicine Bow Energy, Michael Petroleum, Seabulk, and TXU, among others.

About Avista Capital Partners

Avista Capital Partners is a leading private equity firm with offices in New York, NY and Houston, TX. Founded in 2005, Avista manages $2.0 billion in private equity capital. Avista's strategy is to make controlling or influential minority investments primarily in growth-oriented media, healthcare and energy companies. Through its team of seasoned invest
'/>"/>

SOURCE Avista Capital Partners
Copyright©2008 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3

Related medicine news :

1. Boston Scientific Completes Sale of Fluid Management and Venous Access Businesses to Avista Capital Partners
2. Avista Capital Partners Completes Acquisition of Bristol-Myers Squibb Medical Imaging
3. Boston Scientific Agrees To Sell Fluid Management and Venous Access Businesses to Avista Capital Partners for $425 Million
4. HealthpointCapital, LLC Appoints Stephen H. Hochschuler, M.D. as Clinical Advisor
5. MaxLife Fund Corp. and Capital Growth Planning Inc., sign a joint venture agreement
6. Ener1 to Present at February Roth Capital 20th Annual OC Growth Stock Conference
7. CryoCor to Present at Roth Capital Partners 20th Annual OC Growth Stock Conference
8. DATATRAK to Present at the Roth Capital Partners 20th Annual Orange County Stock Conference
9. MGT Capital Investments, Inc. Approves Share Buyback Program
10. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 20th Annual OC Growth Stock Conference
11. Cardiac Science to Present at the Roth Capital Partners 20th Annual Growth Stock Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2010)... N.Y. -- Hockey fans likely would assume that body-checking ... causes the most injuries in youth ice hockey. But ... study, the largest and most comprehensive analysis to date ... overall injuries were caused by accidentally hitting the boards ... by a puck. , Only 34 percent of the ...
(Date:7/29/2010)... more than a thousand genes known as large intergenic ... to understanding the function and organization of the genome. ... with the finding that dozens of these lincRNAs are ... cancer), suggesting that this class of genes plays a ... researchers identify one lincRNA in particular (lincRNA-p21), and demonstrate ...
(Date:7/29/2010)... a family history of male breast cancer perceive themselves to ... patients with a family history of female breast cancer; however ... likely to know about or seek genetic testing than those ... a study led by researchers at the University of Louisville,s ... rare and accounts for only about one percent of all ...
(Date:7/29/2010)... game, developed at the University of Stavanger (UiS), is set ... , If you mention the words "drug calculationss" to a ... in return. Not only is it a difficult subject, the ... mistake in the examination leads to fail, which again bars ... medication can be fatal., At UiS the students have three ...
(Date:7/29/2010)... in Spanish . , Mushrooms are among ... in keeping the immune system healthy. Now, Agricultural Research ... study showing that white button mushrooms enhanced the activity ... In the United States, white button mushrooms represent 90 ... was conducted at the Jean Mayer USDA Human Nutrition ...
Breaking Medicine News(10 mins):Health News:Most youth hockey injuries caused by accidents, not checking, UB study shows 2Health News:'Linc-ing' a noncoding RNA to a central cellular pathway 2Health News:Male breast cancer in family leads to high perception of risk, low likelihood of genetic counseling 2Health News:Male breast cancer in family leads to high perception of risk, low likelihood of genetic counseling 3Health News:Playing with pills 2
... (Nasdaq: WHRT ) World Heart ... Investigational Device Exemption ("IDE") application to the US Food ... pivotal Bridge-to-Transplant ("BTT") study of the Levacor(TM) Ventricular Assist ... information, including design and in vitro and ...
... affected women,s ability to plan and prepare for expensive long-term ... new survey released today by America,s Health Insurance Plans (AHIP). ... found that 60 percent of women say the economy has ... "Women have been particularly hard hit by the ...
... hear it everywhere: "What is your carbon footprint?" But ... can you reduce yours? It isn,t all that complicated, ... to bring it down.Listen to this report from Siemens (NYSE: ... access video, audio, text, graphics and photos for free and ...
... prolongs lives of key vision cells in mice , , ... mice have identified a protein that appears to prolong ... diseased eyes. , The discovery could one day lead ... predisposed to develop retinal disease, the scientists said. , ...
... Yet another reason to use a treadmill desk to ... ... January 8, 2009 -- Yet another alarm bell has been set ... and the corresponding relation to disease. The National Cancer Institute completed ...
... N.C., Jan. 8 Many electronic health record,systems are ... when a child goes to his,or her primary care ... physician,s,office -- the fields in the child,s electronic health ... fields are not appropriate,for newborns; growth tracking and immunization ...
Other Medicine News:Health News:WorldHeart Submits IDE Application for a Pivotal Bridge-to-Transplant Study of the Levacor(TM) VAD 2Health News:Economic Downturn Impacting Women's Ability to Plan for Long-Term Care Costs, New Survey Finds 2Health News:Economic Downturn Impacting Women's Ability to Plan for Long-Term Care Costs, New Survey Finds 3Health News:Protein Might One Day Prevent Blindness 2Health News:Protein Might One Day Prevent Blindness 3Health News:Treadmill Desks Combat Obesity Linked to Higher Rates of Ovarian Cancer 2Health News:Treadmill Desks Combat Obesity Linked to Higher Rates of Ovarian Cancer 3Health News:Alliance for Pediatric Quality Supports New ANSI-Approved Standard for Child Health Passed by HL7 2
(Date:7/29/2010)... Asahi Kasei Medical Co., Ltd. is pleased ... of BioOptimal™ MF-SL, its new range of microfilters ... culture clarification applications, BioOptimal™ MF-SL filters enable biopharmaceutical manufacturers ... harvest step. , ... Developed using Asahi Kasei,s ...
(Date:7/29/2010)... Inc. (Nasdaq: VRML ), a molecular diagnostics company, will host a ... of Q2 financial results on Monday, August 16, 2010 . , ... Conference Call Information ... To access the live ... States and Canada or +1 212 231 2901 internationally. ...
(Date:7/29/2010)... PITTSBURGH , July 29 With diabetes affecting the ... Ohio , Giant Eagle®, Inc. has announced that it will begin ... at no cost to medical prescription holders. , ... (Logo:   http://photos.prnewswire.com/prnh/20100729/NE42933LOGO ) , ... (Logo:   http://www.newscom.com/cgi-bin/prnh/20100729/NE42933LOGO ) , ...
Breaking Medicine Technology:Launch of BioOptimal™ MF-SL Microfilters for Bioprocessing 2Vermillion to Host Conference Call and Web Cast to Present Company Update and Review Financial Results for the Second Quarter 2010 2Vermillion to Host Conference Call and Web Cast to Present Company Update and Review Financial Results for the Second Quarter 2010 3Giant Eagle® Expands Free Prescription Program To Include Free Diabetes Medicines in Western Pennsylvania 2Giant Eagle® Expands Free Prescription Program To Include Free Diabetes Medicines in Western Pennsylvania 3Giant Eagle® Expands Free Prescription Program To Include Free Diabetes Medicines in Western Pennsylvania 4Giant Eagle® Expands Free Prescription Program To Include Free Diabetes Medicines in Western Pennsylvania 5X Chem and Roche Enter Into Drug Discovery Collaboration and License Agreement 16816 1X Chem and Roche Enter Into Drug Discovery Collaboration and License Agreement 16816 2Watson Launches Generic Exelon AE 9552 1Watson Launches Generic Exelon AE 9552 2Watson Launches Generic Exelon AE 9552 3Watson Confirms Columbia Laboratories Shareholder Approval of Proposed Acquisition of Progesterone related Assets 9547 1Watson Confirms Columbia Laboratories Shareholder Approval of Proposed Acquisition of Progesterone related Assets 9547 2Watson Confirms Columbia Laboratories Shareholder Approval of Proposed Acquisition of Progesterone related Assets 9547 3Watson Confirms Columbia Laboratories Shareholder Approval of Proposed Acquisition of Progesterone related Assets 9547 4
... Science Corporation,announced today that enrollment has completed in ... designed to enhance memory. The,IMPACT ("Improvement in Memory ... more than five hundred adults aged 65+,seeking to ... Principal Investigators for the IMPACT trial are ...
... of Phase II Study in Previous Nonresponders ... Schering-Plough,Corporation (NYSE: SGP ) today ... for boceprevir, its investigational oral hepatitis C,protease ... II study in,treatment-naive (previously untreated) hepatitis C ...
Other Medicine Technology:Study Demonstrates Mindful Approach to Aging 2Study Demonstrates Mindful Approach to Aging 3Initial Results of Phase II Study with HCV Protease Inhibitor Boceprevir in Treatment-Naive Hepatitis C Patients Show a High Rate of Early Virologic Response 2Initial Results of Phase II Study with HCV Protease Inhibitor Boceprevir in Treatment-Naive Hepatitis C Patients Show a High Rate of Early Virologic Response 3Initial Results of Phase II Study with HCV Protease Inhibitor Boceprevir in Treatment-Naive Hepatitis C Patients Show a High Rate of Early Virologic Response 4Initial Results of Phase II Study with HCV Protease Inhibitor Boceprevir in Treatment-Naive Hepatitis C Patients Show a High Rate of Early Virologic Response 5Initial Results of Phase II Study with HCV Protease Inhibitor Boceprevir in Treatment-Naive Hepatitis C Patients Show a High Rate of Early Virologic Response 6Initial Results of Phase II Study with HCV Protease Inhibitor Boceprevir in Treatment-Naive Hepatitis C Patients Show a High Rate of Early Virologic Response 7Initial Results of Phase II Study with HCV Protease Inhibitor Boceprevir in Treatment-Naive Hepatitis C Patients Show a High Rate of Early Virologic Response 8Initial Results of Phase II Study with HCV Protease Inhibitor Boceprevir in Treatment-Naive Hepatitis C Patients Show a High Rate of Early Virologic Response 9
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: